Market Tracker

02/22 3:38am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.16
Delayed Data
As of Feb 21
 +0.18 / +18.37%
Today’s Change
0.79
Today|||52-Week Range
4.67
-10.08%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close0.98
Today’s open1.00
Day’s range0.99 - 1.19
Volume1,606,027
Average volume (3 months)294,623
Market cap$18.5M
Data as of 3:59pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-412.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.25

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc+0.05+2.24%
IMMYImprimis Pharmaceuti...+0.01+0.60%
PULMPulmatrix Inc+0.02+1.37%
TCONTRACON Pharmaceutica...-0.05-2.27%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$2.06
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts